Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography

NCT04640350 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT04640350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04640350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2020
Completion date
May 31, 2023
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal varices, liver cirrhosis, variceal hemorrhage